Will CytoDyn (CYDY) Get Out of Fragile Moves Amid Prepping COVID-19 Vaccine?

Following the announcement of a joint venture, made 3 days ago, against Covid-19, with Philippine Airlines, the CYDY stock is volatile. After the announcement, on the same day, the shares soared from $1.9 to $2.17, but in the last 4 days, the shares are rising and falling, demonstrating the ambiguity of the situation.

Will CytoDyn (CYDY) Get Out of Fragile Moves Amid Prepping COVID-19 Vaccine?

In the coming months, the corporations plan to offer “leronlimab” vaccine to the Philippines’ population. Many patients and their doctors are quite enthusiastic about the use of “leronlimab” in the CSP in the Philippines, which could raise the company’s stock.

Related:  Under $3 CytoDyn (CYDY) shares rise towards $7

According to the graph, the stock price has lost value over the last six months, and they developed a plan this month to recover quarterly profit. In the coming months, the company expects a steady increase in shares, investors should watch the development of the company.

Anthony Gonzales

Biotech, Tech, and Crypto reporter Anthony Gonzales brings 3 years of experience in helping grassroots, mid-sized organizations and large institutions strengthen their management and resource generating capacities and effectively plan for the future. He is also a mentor and professional advisor to artists working in all disciplines. He is the gold medalist from St. Marco University of Science and Technology in the Bachelors of Financial Management as well.